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Summary 
A common feature ofT cell acute lymphoblastic leukemias (T-ALLs) is the presence of structural 
alteration of the 5' part of the tal-1 locus, localized on chromosomal band 1p32. These alterations 
consist  of  either  a  t(1;14)(p32;q11)  chromosomal  translocation  (3%  of  T-ALLs)  or  tal  d 
submicroscopic deletion (12-25%  additional T-ALLs).  We have characterized a case of T-ALL 
with t(1;14)(p32;q11)  in which, unlike the majority of t(1;14),  the recombination with the T 
cell receptor/~ elements affected the 3' side of the tat-1  locus. In this case, tal-1  transcription 
is initiated from a promoter located within the fourth exon similarly to the DU 528 cell line. 
In a T-ALL bearing a t(1;14)  affecting the 5' part of ta/-1,  two types of tal-1 transcripts were 
observed, namely those probably initiated from the D8 region  juxtaposed to tal-1 by the translocation, 
and those from the exon 4 promoter. It is interesting that this exon 4 promotion was also found 
in leukemic T cell lines and T-ALL samples without apparent tal-1 genomic alteration. In contrast, 
no transcript initiated from the exon 4 promoter was found in T-ALL with tal  dl or tal  d2 deletion. 
In these cells, tal-1 is expressed via Sllctal-1 fused transcripts. Finally,  this exon 4 initiation was 
detected neither in normal bone marrow, nor in malignant cells from the erythroid/megakaryocytic 
lineages. Taken as a whole, these data suggest that the exon 4 promoter is specifically  active 
in T  cell lineage. 
T 
he tab1 gene (also called TCL15 or SCL) was identified be- 
cause of its involvement in the t(1;14)(p32;q11)  translo- 
cation  in  T  cell  acute lymphoblastic  leukemia  (T-ALL) l 
(1-4). It belongs to a family of genes, the products of which 
are defined by a primary amino acid motif referred to as the 
basic region-helix-loop-helix (bHLH) motif. This motif is 
a dimerization and DNA binding motif common to a number 
of proteins involved in the control of cell growth and differen- 
tiation (5, 6).  Some members of this family such as c-myc 
are also implicated in human leukemogenesis~ Beside the strong 
association of tal-1  with T-ALL,  two closely related genes, 
designated  as  ta/-2  and  lybl,  have  been  characterized in 
t(7;9)(q35;q32) and t(7;19)(q35;pD), respectively (7, 8). Be- 
cause these chromosomal abnormalities are found in T-ALL, 
these results are highly suggestive of a specific involvement 
of this gene family in T-ALL leukemogenesis. 
Abbr~iations used in this paper: bHLH, basic region-helix-loop-helix; 
OR.F, open reading frame; nt, nucleotide; T-ALL, T cell acute lymphoblastic 
leukemia. 
Genomic rearrangements of the tam locus frequently occur 
in T-ALLs in two different ways. The most common altera- 
tion (12-25%  of T-ALL patients) is a submicroscopic dele- 
tional  event,  tal  d,  that  leads to  a  90-kb  deletion of 1p32 
chromosomal sequences, centromeric to the tal-1 gene. The 
telomeric endpoint of the deletion lies within the 5' part of 
the tal-1  locus, either between the two first exons (tal  dl) or 
2-kb  upstream  (tala2), outside  of the  transcribed  region 
(9-12). In both tal  ~ situations, the 5' untranslated region of 
another gene, named SIL, lies at the centromeric end of the 
deletion. As a result, a fused SIl.,tal-I  transcript has been iso- 
lated in the talal-beafing HSB-2 T cell line (11, 13). Similar 
fusion transcripts have been recently reported from varying 
tal  ~ patients  (12). 
An additional 3% ofT-ALL patients present a t(1;14)(p32; 
q11) translocation (14). In six of the seven cases studied at 
the molecular level,  the recombination, which is likely to 
be due to lymphoid recombinase activity, was shown to occur 
between TCR-~ and the tat-1 locus. The lp32 breakpoints 
are clustered within 1 kb, surrounding the third exon oftal-1 
(9,  15,  16). In the DU 528 cell line, derived from an acute 
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lated part of the gene (17).  When tested, t(1;14)  transloca- 
tions are associated with a high level of ta/-1 gene expression 
(1,  2).  Since,  up to now,  tab1 expression has not been de- 
tected in normal T lymphocytes, the transcriptional deregu- 
lation of ta/-1 by deletion or translocation  is likely to be a 
critical  factor in T  cell leukemogenesis  (9,  10,  11,  16). 
Recently, Xia et al. (18) described a case of t(1;14) in which 
the  lp32 breakpoint  differed from the previous ones since 
it was localized 25 kb downstream of the tal-1 gene. A more 
distal breakpoint (35 kb) was characterized by Fitzgerald et 
al. (19) during the study ofa t(1;7)(p32;q35)  involving TCR-fl 
on 7q35. In these two cases, the consequences of these lp32 
rearrangements  on tal-1 expression were not investigated. 
We report thereafter the molecular analysis  of a new case 
of t(1;14) in a T-ALL.  Recombination occurred between the 
TCK-# gene on chromosome  14,  and  a 1p32 segment lo- 
cated 5.5 kb downstream of the tal-1 transcription  unit.  In 
this case, tal-1 transcription  was shown to be initiated only 
within the fourth exon of the gene as observed in DU 528 
cells (9, 16). This initiation was also evident in another t(1;14) 
T-ALL (in which the breakpoint is located in the third exon 
of ta/-1 [9]) and in T-ALL without evident genomic altera- 
tion of the tal-1 locus. In contrast,  this peculiar exon 4 pro- 
motion was not detected either in normal bone marrow, nor 
in malignant cells from the erythroid/megakaryocytic lineages, 
suggesting that  it might be T  cell specific.  This initiation 
was not detected either in tal  dl and tal  d2 samples.  In those 
cases, our investigations confirm that both types of tal  d simi- 
larly result in Slbtal-1  fusion transcripts  (11). 
Mat~riah and Methods 
Cells and Cell Lines.  The patient was a 23-year-old male with 
T-ALL. At diagnosis, the white blood count was 380  x  109/liter 
with 92% lymphoblasts. Bone marrow was invaded by 95% lym- 
phoblasts. Surface markers were: CD2 +, CD5 +, CD7 +, CD4 +, 
CD8 +, CD3-, and intracytoplasmic CD3 +. Cytogenetic  analysis 
revealed an abnormal  karyotype:  46,XY, t(1;14)(p32;q11), inv(7)- 
(p15q35) in 11 mitoses, and a normal 46,XY in 28. The patient 
entered complete remission after intensive chemotherapy. Patient 
material analyzed in this report is a leukemic blood sample obtained 
just before treatment. 
Patients samples were provided by the Hematology Department 
of H6pital Saint-Louis (Paris, France). Cell lines were cultivated 
in RPMI 1640 10% FCS as described (2, 9). 
Southern Blots.  DNA was extracted as described (2). Southern 
blot hybridization  was carried out in 0.5 M NazHPO4, pH 7.2, 
7% SDS, I mM EDTA, with radiolabeled probes at 68~  Washes 
were carried  out in 40 mM NaHzPOJNazHPO4,  1%  SDS at 
68~  (20). 
Probes were isolated as described (2, 21) and were as follows: 
the D81/2 probe is a 1.8-kb BamHI-EcoRI fragment; tbeJ/~l probe 
is a 1.5-kb XbaI-EcoKI fragment,  and J/~3 is a 0.56-kb  EcoRV- 
XbaI fragment. 
RNase Protection Assay.  RNA was extracted  by guanidium 
isothiocyanate disruption  of the ceils followed by cesium chloride 
selection or phenol  extraction  (2, 22). 
Uniformly labded 32P-antisense RNA was synthesized  from 
relevant fragments  subdoned in pGEM or Bluescript  by using 
Promega Corp. (Madison, WI) reagents. 2  x  10  s cpm of antisense 
RNA was hybridized to 5-20/zg of test RNA samples in 80% 
formamide for 16 h at 65~  After RNase A digestion,  samples 
were  phenol/chloroform  extracted,  ethanol  precipitated,  and 
analyzed by electrophoresis on a 5% acrylamide-7 M urea dena- 
turing gel. 
PCR Experiments.  Bi-specific  PCK was performed on genomic 
DNA or on random-primed  cDNA as previously described (9). 
Oligonucleotides,  provided by Genset (Paris, France) were JU5': 
ATGGATACAGAGCCCTTCCAC;  JU3':  CTGCAGGGGCTG- 
GTCCAAAG;  D82:  AGCATTGGTGAAAGGAGTTC;  J83': 
AGAGTTTGAIGCCAGTTCCG;  SIL: TGCAAACAGACCTCA- 
GCTC; Z2: TTC~AGA~CTC~AG~  and Z8: CTCCCG- 
GCTGTTGGTGAA.  Z2 and 7_,8 correspond to ta/-1 exons 3 and 
6, respectively. 
Anchored PCK was performed as described (23, 24) using suc- 
cessively nested  oligonucleotides,  ZS,  Z7  (GGGACCATCAG- 
TAATCTCC),  and Z3 (AAGGCATCCGGCTCCCCAAA). 
Results 
t(1;14) inJU Cells Affects the 3' Part of the tal-1 Gene.  Leu- 
kemic cells obtained at diagnosis from patient JU showed 
a typical t(1;14)(p32;q11) translocation. To determine whether 
the chromosome 1 breakpoint occurred within the ta/-1 locus, 
we performed Southern blot experiments with probes en- 
compassing 35 kb of the tal-1 locus. No rearranged fragments 
were detected with probes derived from the 5' part  of the 
gene.  On the other hand,  probes derived from the 3' part 
of ta/-1 revealed an abnormal pattern in addition to the germline 
pattern.  More precisely, a 0.6-kb PstI fragment was able to 
detect two rearranged fragments and a germline, one in each 
digest (Fig. 1). These rearrangements  were likely to correspond 
to both chromosomal translocationjunctions and allowed us 
to map the putative breakpoint at 5.5 kb downstream of the 
tal-1 polyadenylation signal. 
Much as we had with the previously reported t(1;14) cases, 
we reasoned that the chromosome 14 breakpoint could in- 
volve the TCR-~ gene. Genomic probes covering either the 
D/~1/2 (Fig.  1) or the J~l (data not shown) regions detected 
only one rearranged  fragment in each digestion.  The same 
blot hybridized with a J~3 probe, revealed  rearranged  frag- 
ments in addition to the germline fragments. The D#2 rear- 
ranged fragments did not comigrate with those detected by 
the J61 or J/~3 probes,  which suggests that  they were not 
a result of an incomplete D-J assembly. The presence of three 
different rearrangements within TCR-~ locus suggested that 
some of them may correspond to the translocated gene seg- 
ment.  Actually,  the D/~1/2 rearranged  fragment  was iden- 
tical in size to the ta/-1 abnormal one. Similarly, the size of 
the J/~3 additional fragment was identical to the other tal-1 
rearranged fragment. These data were consistent with a V-J61 
assembly on one allele and the translocation-associated rear- 
rangement  affecting D/~1/2  and J~3 on the other  allele. 
To confirm the data deducted from the Southern blot anal- 
ysis,  we cloned the potential chromosomal breakpoints by 
PCR. The nucleotide (nt) sequence of the 0.6 PstI fragment 
was determined to select two oligonucleotides on each side 
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tion in JU T-ALL. (A) Schematic map of the TCR- 
or/6 locus at 14q11. The location of the probes is un- 
derlined. (13) Southern blot analysis of  JU blast DNA 
and germline  control (I-IEL cell line DNA) digested 
by EcolLl (E), HindlII (H), BamHI (13), and PstI (Ps) 
hybridized with indicated probe. (am) Germline frag- 
ments. (~) Rearranged fragments.  (Left) Hybridiza- 
tion with D/$1/2 genomic probe. This probe detects 
abnormal fragments in JU leukemic cell DNA. Sub- 
molar germline fragments  are certainly derived from 
nonleukemic  cells present in the blood sample. The 
Di~l/2 probe detects two germline fragments because 
it possesses an HindlII internal site. (Middle) Hybrid- 
ization with the 0.6-kb Pstl probe. In each digest, this 
probe detected two abnormal  fragments  in addition 
to germline chromosome 1 fragments. Note that hy- 
bridization  intensity of the rean'anged fragments cor- 
responding to the 14q- junction is very weak because 
the breakage occurred at 60 nucleotides from the edge 
of the probe. This fragment is not detectable in the 
EcoRI digest.  (Right)  Hybridization with  the J63 
probe. Germline fragments  are revealed in each lane. 
Rearranged fragments were also detected in DNA from 
JU leukemic cells. (C) Restriction  map of the tam 
locus. (4) Location of tald and t(1;14) breakpoints. The 
location  of the 0.6 PstI probe is underlined. 
of the putative breakpoint ~JUS' and JUY). They were used 
in PCR experiments together with specific D/$2 or J/~3 oli- 
gonucleotides. Amplified fragments were size selected, cloned 
in T vectors (25,  26), and sequenced. Nudeotide sequences 
of both t(1;14) junctions were compared with their germline 
counterparts (Fig.  2). 
The alignments indicated that the breaks on chromosome 
14 had occurred at the recombination signals,  respectively 
3' of the D~2 segment and 5' of the J/~3 segment. They also 
revealed the loss of one nucleotide from chromosome 1 and 
the presence of nucleotide stretches at the translocationjunc- 
tions (30 nudeotides at the der(1)junction and 2 nucleotides 
at the der(14) junction), which were derived from neither 
chromosome 1 nor 14. This situation is reminiscent of N 
insertion associated with normal V(D)J assembly (27).  Al- 
together, these data implicated the recombinase complex in 
the mechanism of the translocation. 
Initiation of  tal-1 Transcription  within Exon 4 Specifically Occurs 
in Leukemic  T  Cells.  Under normal conditions, at least five 
tal-1 mRNA species result from two distinct promoters (IA 
and IB), differential splicing, and alternative exon usage. Two 
main transcripts can be distinguished with respect to their 
coding capacity, depending upon the presence or absence of 
exon 4. These two types encode either a 40- or a 25-kD pro- 
tein, which differ from each other by their NH2 terminus 
(9,  15,  28). 
The expression of tal-1 in leukemic T cells bearing a t(1;14) 
translocation has been documented in only two cases: pa- 
tient Kd (2) and the DU 528 cell line (1, 2). In the case of 
Kd, in which the breakpoint was mapped at the 5' part of 
exon 3, Northern blot analysis revealed a 5-kb species, but 
was not informative with respect to transcription start site. 
In DU 528 cells, in which the translocation breakpoint is 
located within the last exon, a transcript is initiated within 
exon 4  and contains TCR-~ sequences in its 3' part,  thus 
leading to a truncated hybrid mRNA (17). We wondered 
whether the use of this cryptic promoter internal to exon 
4 was found in other malignant cells. For that purpose, we 
designed a RNase protection assay that discriminates between 
transcripts containing the totality of the fourth exon, and 
transcripts initiated within exon 4. 
RNase assay was performed using a series of KNAs ex- 
tracted from T-ALL patients and established  T  cell lines (a) 
associated with t(1;14) translocation (patients: Kd, JU, and 
DU 528 cell line); (b) associated with tal  a (patients Leb, 7, 
and 414, and cell lines HSB-2, RPM18402, and CCRF-CEM); 
and (c) devoid of apparent tal-1 genomic alteration (patients 
Bur.,  109,  and Vii.,  and cell lines Rex  and Jurkat).  The 
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Figure 2.  Molecular cloning of t(1;14) in JU leukemic cells, (~p) Par- 
tial restriction map of germline  and translocated alleles  of  JU. Not all sites 
are shown. (Bottom)  Comparison of nucleotide sequences encompassing 
translocation breakpoints  and normal counterparts.  14qll germline se- 
quences are from references 35 and 36. Recombination signals are under- 
lined. N nucbotides are in lowercase letters. These sequence data are avail- 
able from EMBL/GenBank/DDBJ under accession number X67500. 
erythroid (K562 and HEL) and megakaryocytic (MEG-01) 
leukemic cell lines, which are also devoid of any detectable 
tal-1 genomic abnormality,  were included as controls,  since 
we have previously shown that they express high levels of 
tal-1  transcript  (Mouthon, M.-A., O. Bernard, M.-T.  Mit- 
javila, P.-H. Romeo, W. Vainchenker,  and D. Mathieu-Mahul, 
manuscript submitted for publication). 
From the data presented on Fig. 3, we distinguish  three 
different situations:  first, cases where a unique fragment of 
413 nt is protected, which corresponds  to transcription  of 
the entire exon 4 (plus exons 5 and 6). This situation is found 
in the three cell lines MEG-01, HEL, and K562, and in tal  d- 
bearing cells. Second, cases where a faster migrating frag- 
ment of  380 nt is protected and the 413-nt fragment is missing, 
as in DU 528 cells and in JU sample. Finally, both 413- and 
380-nt fragments may be present simultaneously, as observed 
in the case of T-ALL patients Bur, 109, and Kd, and in Rex 
andJurkat T cell lines. According to previous studies on DU 
528 cells (9, 16), we interpret the protection of the 380-nt 
fragment as reflecting the initiation of transcription  within 
exon 4, whereas the protection of the 413 nt fragment, is 
considered to reflect regular transcriptional  initiation of un- 
rearranged  tal-1 gene,  since it is observed in normal bone 
marrow. It should be noted that the 380-nt  fragment was 
not detected in the control myeloid cell lines. To test whether 
this initiation could occur in other cell types, we performed 
RNase assays with RNAs from several origins. The 380-nt 
fragment was not protected  by RNAs from leukemic samples 
of patients  with chronic myelogenous leukemia (CML)  or 
acute megakaryocytic leukemia (AML-7), nor from a preB 
cell line (Nalm 6). Regular tal-1 expression in these cells was 
asserted by the presence of the 413-nt fragment. We noticed 
a faint band at 380 nt position in the lane corresponding to 
MEG-01, which we attribute to the high level of tal-1  tran- 
scription  in this cell line. 
To summarize,  the initiation of transcription  within the 
fourth exon was detected only in leukemic T cells. In addi- 
tion, this initiation is the only one detected in those DU 
Figure 3.  RNase protection experiments. The probe is a 413-nt cDNA fragment  obtained after ExollI digestion  and contains a part  of exons 4, 
5, and 6 up to Sad site. (Black box) Vector polylinker sequences. A fragment of 413 nt, representing a full-length protection is seen in most samples. 
With the e~.ception of raid-bearing cells, all lanes corresponding  to T cell lines or T-ALL samples show a '~380-nt fragment  representing protection 
of •200  nt of the 3' part of exon 4. 
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points 3' of ta/-1. 
In contrast, no transcript starting from this promoter was 
detected in any of tal  a leukemic cells tested. Aplan et al. (12) 
isolated in the tal  d*- bearing HSB-2 cell line a fusion tran- 
script initiated at SIL exon 1 and spliced to tal-1 exon 3. To 
compare  the  nature  of tal-1  transcripts  between tal  d*- and 
tala2-bearing  cells, anchored PCR technique was performed 
on tal  al CCRF-CEM RNA and tal  d2 T-ALL RNA (Fig.  4). 
By using oligonucleotides corresponding to tal-1 exons 5 and 
6 (Fig. 4), two types of cDNAs were identified in both samples. 
The first type contained SIL exon 1 and tab1 exons 3, 5, and 
6. The second type also contained SIL  exon  1 plus a part 
of SIL intron  1. In this case, a downstream donor site was 
used to directly splice SIL  sequences to tal-1  exon 5,  then 
spliced to exon 6. No cDNA containing exon 4 was isolated. 
The discrepancy between these data and those of RNase assays 
presented above is presumably due to the dif~cuhy of reverse- 
transcribing  and amplifying the CG-rich region appearing 
within  exon 4. 
To confirm the presence of fusion messages in other tal  d- 
bearing cells, bi-specific PCR experiments were performed 
using primers  corresponding  to SIL  exon 1 and tal-1  exon 
3 or 6.  One tal  dl and two tal  a2 patients were found to ex- 
press both types of transcripts. 
SlL 
T 
1  ~k 
,  D 
,  t-I 
3  D 
lal  ~  tal dl 
T  T 
1A IB 
SIL  genornic  sequence 
T  C,  CAAACAC,  ACC  TCAC,  C  TC  C  C-C  GGAAGn'TC~ G  /  GTAAGTGGAC-CZnnGTGC 
TCC~  TCCTC-GCCCCTTGAGAC, CCC-GCAC-CGGGGC  CC  TC,  GGA 
AGGTI'C~TGGGTAACATI'CAAAGC C  C  "f%'TA~  C  GC  CC  TC  CAC4A 
GCCTGGAC,  CAGATGACGAGAAGGC,  C-A~A~GAAATTAAGCAGTC 
CATGAAATCCTTGGGTATCTGAGCTAAG /  GTATGTGAAAGAGGTTTGCAGT 
CGATAACGTGCCATTTAAA 
transcript  1  :  SIL  ex.  1  splice  5']ta]-I  ex.  3/  Ex.  5 
~,/T~jE~X~  GCGGAAGTTC-C  G  /  ATC  GCCCAGGACCACACCG 
CAGCGTAACTC,  C~GGC  CTCTCAGC  C,  AAAAA~GCAAAGAC  CCGGGT 
GTOCATCCTCTTCCTC GGCTTCCC,  CCCCTTTCCGGCGGAGTGGAGATC CTAT 
TCAGAGGGGCCGGTCTCTCTAAATATGCCCCAG/  Ex.  4 
transcript  2  :  S1L  ex.  1  splice  3'/tal-I  Ex~  5 
~EC./S~%~r 
TCCTC~TITGTC~TCC'I'C,C-CCC~GAC, CgC~GCGGGC~CCTGGGA 
A~AACATTCBAAGCCCTGTAGTGC-GTTCCGCCCTCCAGGA 
GC  CTGGAGCAGATGACGAGAAC~GGAGC TAG~GAAATTAAGCAGTC 
CATGAAATCCITC,  GGTA~C,C  TAAG  /  C  C-C-G'ITC  ~GC C  C,  GAT 
GC  s 
CTATGAGATGGAGATTACTGATOGT  / 
Figure 4.  tal-1 transcription  in  tala-bearing  cells. (~p)  Schematic 
drawing (not to scale) of SIbtal-I fusion transcripts.  (V) Deletion break- 
points. (Bottom) Nucleotide sequence of genomic $IL exon I/intron I (10) 
and of representative cDNA amplified from tala-bearing cells. The SIL 
oligonucleotide  is underlined.  Splice sites are marked. 
Discussion 
We have analyzed a new case of t(1;14)(p32;qll) in a T-ALL 
patient (JU). In agreement with cytogenetic observation, the 
translocation breakpoints were localized within the TCR-/~ 
gene,  on band  14q11, and in the vicinity of the ta/-1  gene 
on band lp32.  Involvement of D/$2 and J/~3 segments and 
nucleotide sequence comparison of chromosomal junctions 
to their germline counterparts argued in favor of a recom- 
binase mediated  transtocation  process. 
To date, most of t(1;14)  breakpoints affect the 5' side of 
ta/-1 and are clustered within I kb. In the JU case, the trans- 
location breakpoint was located 5.5 kb downstream of the 
tat-1 polyadenylation site. In the four cases currently described 
which affect the 3' side of tal-1  (three t(1;14)  and one t(1;7) 
translocations),  the  sites  of breakage  appear  to  be  quite 
dispersed since they are spread over 40 kb, from within the 
tal-1  transcription  unit (DU 528) to 35 kb downstream of 
the gene (19). 
Since the translocation breakpoints are located either up- 
stream or downstream of the tal-1  gene,  it was of evident 
interest to examine the possible consequences of both situa- 
tions on its transcription.  Previous studies indicated that in 
the DU 528 cell line,  the tal-1  transcription  start  site was 
located within exon 4, whereas no transcript  was found to 
be initiated  at  the regular promoters  1A or  1B (9,  15).  It 
is interesting that an identical situation was observed in the 
case of  JU leukemic cells. On the other hand, in Kd leukemic 
cells in which the t(1;14)  break is located in the 5' part of 
the gene (9), our data indicated that transcription initiation 
can occur simultaneously within the fourth exon of tal-1 and 
from an upstream promoter.  In view of the position of the 
translocation  breakpoint,  the promotion  may occur either 
in the tal-1  exon 3/intron  3, or more probably, within the 
D/$ region. 
Transposition of TCR-/~ regulatory elements in the vicinity 
of the tal-1  gene by the t(1;14)  translocation,  is supposed to 
influence tal-1  transcription,  as it is initiated at the peculiar 
promoter located in exon 4. When breakage occurs 3' of tal-1, 
the direct juxtaposition of the TCtL-/~ enhancer (29, 30) to 
tam  sequences appears to dictate the transcription  to start 
exclusively at this internal promoter. When breakage affects 
the  5' part  of tal-1,  a dual promotion  (within  exon 4 and 
upstream)  is observed and is probably due to the presence 
of as yet uncharacterized D~ regulation elements. By analogy 
with the situation described for the TCR-fl and IgH genes 
(31, 32), the upstream initiated transcript may start within 
the D8 region and go on through the tal-1 sequences. In this 
respect, it is worth emphasizing that most chromosomal trans- 
locations involving the TCR-/~ gene, result in the relocation 
of the D8 region to the 5' side of putative oncogenes fre- 
quently associated with  truncation  of the gene (33). 
Transcriptional  initiation  within exon 4 is also observed 
in T-ALL samples without evident ta/-1 gene alteration. Thus, 
this peculiar initiation  is not linked to the translocation it- 
self, but rather reflects the activation of a functional promoter. 
Two observations suggest that  the use of this exon 4 pro- 
moter is restricted to T cell lineage.  First, in a survey of he- 
923  Bernard  et al. matopoietic cell lines and leukemic cell samples, this promo- 
tion within exon 4 was observed only in malignant T cells. 
Second,  we did not detect the utilization of this promoter 
in normal bone marrow. The most 5' AUGs (corresponding 
to no. 3 and no. 4 in the large open reading frame (ORF) 
[9, 16]) present in this mRNA species were found to be weak 
translation initiation codons in in vitro experiments (9). In 
this respect,  the translation should start at the third AUG 
(corresponding to no. 5 in the large ORF) and produce the 
25-kD protein (9,  16,  28). 
It is notable that the exon 4 promoter activity was not 
found in any tal  d leukemic samples.  Indeed, in both types 
of deletions (tal  al  and taldZ), tal-1 sequences  are  expressed 
through fusion transcripts initiated at the SIL gene promoter. 
To explain the lack of exon 4 promoter usage in tal  d leu- 
kemic cells, one can speculate that the tal-1 protein translated 
from SIL-tal-1  mRNA acts negatively onto this promoter 
by a feedback mechanism, and that SIL regulatory elements 
are unable to cis-activate  this tal-1 promoter. 
In the course of the analysis of the mRNA species associated 
with both tal  d, we identified at least  two types of fusion 
transcripts. The first one fuses SIL exon 1 sequences to tal-1 
exon 3,  and the second one splices the first intron of SIL 
directly to ta/-1 exon 5. In no case, is an in-frame AUG codon 
introduced upstream of the tal-1 reading frame, which rules 
out translation of a fusion protein. Therefore, although tal  ~ 
does not directly affect the tal-1 transcriptional unit as does 
tal  dl,  both  have  similar effects  on ta/-1 expression.  These 
results confirm those recently published by Aplan et al. (11). 
Throughout this study, we characterized ta/-1 expression 
in some T cell lines and T-ALL samples without any obvious 
tal-1 genomic rearrangement. In these cases, transcriptional 
initiation was shown to involve both exon 4 promoter (this 
paper) and promoter 1B, and, in one case of T-ALL, also pro- 
moter 1A (data not shown). 
In  conclusion,  it  appears  that  the  exon  4  promoter  is 
specifically used in T-ALLs with t(1;14)  translocation and 
T-ALLs without evident tal-1 genomic rearrangements. In 
tal  a T-ALLs, the transcription of ta/-1 is under the depen- 
dence of the modified SIL  gene. 
Up to now, tal-1 expression has not been detected in normal 
T cells. However, the possible involvement of the lymphoid 
recombinase in the genesis of t(1;14) and tal  d in T-ALLs, sug- 
gests that these illegitimate recombinations occur during early 
T  cell development. The association of tal  d occurrence in 
T-ALLs with the commitment to the TCR-ol/B lineage sup- 
ports this hypothesis (34). In that respect, one can speculate 
that tal-1  expression  occurs at some specific stages  during 
thymic ontogeny. 
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